Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Johns Hopkins School of Medicine: Baltimore, Maryland, US

Assistant Professor
Employment
Source: Self-asserted source
Catherine Marshall

Education and qualifications (3)

Johns Hopkins School of Medicine: Baltimore, MD, US

2007 to 2012 | M.D.
Education
Source: Self-asserted source
Catherine Marshall

Johns Hopkins Bloomberg School of Public Health: MD, MD, US

2010 to 2011 | M.P.H
Education
Source: Self-asserted source
Catherine Marshall

Harvard University: Cambridge, MA, US

2002 to 2006 | A.B.
Education
Source: Self-asserted source
Catherine Marshall

Funding (1)

Cardiorespiratory Fitness

2017-07 to 2018-06 | Grant
Conquer Cancer Foundation (Alexandria, US)
GRANT_NUMBER:

11222
Source: Self-asserted source
Catherine Marshall

Works (28)

Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer

The Prostate
2025-03 | Journal article
DOI: 10.1002/pros.24841
Contributors: Etan R. Aber; Michael A. Carducci; Channing J. Paller; Sam R. Denmeade; Kelli Rourke; Catherine H. Marshall; Mark C. Markowski
Source: check_circle
Crossref

Germline–Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality

Clinical Cancer Research
2025-03-28 | Journal article
DOI: 10.1158/1078-0432.CCR-24-2058
Contributors: Ali T. Arafa; Siddhartha Yadav; Catherine H. Marshall; Elizabeth Mauer; Minxuan Huang; Binyam Yilma; Ymke van der Pol; Stamatina Fragkogianni; Emily A. Teslow; Samuel Kellen et al.
Source: check_circle
Crossref

Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes

2025-02-24 | Other
DOI: 10.1093/oncolo/oyaf049
Contributors: Catherine Marshall; Yasaman Iranmanesh; Noha Omar; Arya Rasouli; Alex Baras; Sergiu Pasca; Lukasz P. Gondek; Hua-Ling Tsai; Samuel R. Denmeade; Michael A. Carducci et al.
Source: check_circle
Crossref

Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting

The Prostate
2024-08 | Journal article
DOI: 10.1002/pros.24721
Contributors: Andrea K. Miyahira; Sophia C. Kamran; Tamara Jamaspishvili; Catherine H. Marshall; Kara N. Maxwell; Abhijit Parolia; Nicholas A. Zorko; Kenneth J. Pienta; Howard R. Soule
Source: check_circle
Crossref

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

The Prostate
2024-07 | Journal article
DOI: 10.1002/pros.24712
Contributors: Catherine H. Marshall; Lukasz P. Gondek; Violet Daniels; Changxue Lu; Sergiu Pasca; Jiajun Xie; Mark C. Markowski; Channing J. Paller; Laura A. Sena; Samuel R. Denmeade et al.
Source: check_circle
Crossref

Acting on Actionable Mutations in Metastatic Prostate Cancer

Journal of Clinical Oncology
2023-06-20 | Journal article
DOI: 10.1200/JCO.23.00350
Contributors: Catherine H. Marshall
Source: check_circle
Crossref

Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6530555
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6530555.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S1 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480919
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S1 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480919.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S2 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480916
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S2 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480916.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S3 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480913
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S3 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480913.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S4 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480910
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Figure S4 from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480910.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Supplementary Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480907
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Supplementary Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22480907.v1
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Cancer Research
2022-11-15 | Journal article
DOI: 10.1158/0008-5472.CAN-22-0985
Contributors: Catherine H. Marshall; Lukasz P. Gondek; Jun Luo; Emmanuel S. Antonarakis
Source: check_circle
Crossref

Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability

Clinical Genitourinary Cancer
2022-04 | Journal article
DOI: 10.1016/j.clgc.2021.11.015
Contributors: Aline B.L. Gongora; Catherine H Marshall; Pedro Isaacsson Velho; Carlos D.H. Lopes; José F. Marin; Anamaria A. Camargo; Diogo A. Bastos; Emmanuel S. Antonarakis
Source: check_circle
Crossref

Clinical and genomic features of SPOP‐mutant prostate cancer

The Prostate
2022-02 | Journal article
DOI: 10.1002/pros.24269
Contributors: Mari Nakazawa; Mike Fang; Catherine H. Marshall; Tamara L. Lotan; Pedro Isaacsson Velho; Emmanuel S. Antonarakis
Source: check_circle
Crossref

Reversing the effects of androgen‐deprivation therapy in men with metastatic castration‐resistant prostate cancer

BJU International
2021-09 | Journal article
DOI: 10.1111/bju.15408
Contributors: Catherine H. Marshall; Jessa Tunacao; Varun Danda; Hua‐Ling Tsai; John Barber; Rakhee Gawande; Clifford R. Weiss; Samuel R. Denmeade; Corinne Joshu
Source: check_circle
Crossref

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

Journal of Urology
2021-09 | Journal article
DOI: 10.1097/JU.0000000000001797
Contributors: Catherine Handy Marshall; Yongmei Chen; Claire Kuo; Jennifer Cullen; Jiji Jiang; Inger Rosner; Mark Markowski; David G. McLeod; Bruce J. Trock; Mario A. Eisenberger
Source: check_circle
Crossref

Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease

European Journal of Internal Medicine
2021-05 | Journal article
DOI: 10.1016/j.ejim.2021.02.003
Contributors: Seamus P. Whelton; Philipp Berning; Roger S. Blumenthal; Catherine Handy Marshall; Seth S. Martin; Martin Bødtker Mortensen; Michael J. Blaha; Omar Dzaye
Source: check_circle
Crossref

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Clinical Cancer Research
2021-03-15 | Journal article
DOI: 10.1158/1078-0432.CCR-20-4476
Contributors: Catherine H. Marshall; Wei Fu; Hao Wang; Jong Chul Park; Theodore L. DeWeese; Phuoc T. Tran; Daniel Y. Song; Serina King; Michaella Afful; Julia Hurrelbrink et al.
Source: check_circle
Crossref

Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium

American Journal of Preventive Cardiology
2020-12 | Journal article
DOI: 10.1016/j.ajpc.2020.100119
Contributors: Frances M. Wang; Cara Reiter–Brennan; Zeina Dardari; Catherine H. Marshall; Khurram Nasir; Michael D. Miedema; Daniel S. Berman; Alan Rozanski; John A. Rumberger; Matthew J. Budoff et al.
Source: check_circle
Crossref

Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium

The American Journal of Medicine
2020-10 | Journal article
DOI: 10.1016/j.amjmed.2020.02.034
Contributors: Seamus P. Whelton; Mahmoud Al Rifai; Catherine Handy Marshall; Zeina Dardari; Leslee J. Shaw; Mouaz H. Al-Mallah; Alan Rozanski; Martin B. Mortensen; Omar Dzaye; Lydia Bazzano et al.
Source: check_circle
Crossref

Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort

Cancer
2019-08 | Journal article
DOI: 10.1002/cncr.32085
Contributors: Catherine Handy Marshall; Mouaz H. Al‐Mallah; Zeina Dardari; Clinton A. Brawner; Lois E. Lamerato; Steven J. Keteyian; Jonathan K. Ehrman; Kala Visvanathan; Michael J. Blaha
Source: check_circle
Crossref

Peer review (6 reviews for 4 publications/grants)

Review activity for Cancer causes & control. (1)
Review activity for PloS one. (1)
Review activity for Prostate cancer and prostatic diseases (3)
Review activity for The oncologist. (1)
How many people are using ORCID?